Clinical Trials Directory

Trials / Unknown

UnknownNCT04816786

COVID-19 Patients Admitted to the ICU

Prognostic Factors and Predictors of Mortality in COVID-19 Patients Admitted to the ICU. An Aid for Triage, Counseling, and Resource Allocation

Status
Unknown
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Ministry of Health, Kuwait · Other Government
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

A retrospective analysis of the adult COVID-19 patients admitted to the ICU. A chart review will be conducted and multiple baseline characteristics, demographics, and treatments given will be recorded. Variables collected will include Age, Gender, BMI, Smoking status, Past medical history, Vital signs on admission, symptoms on admission, duration of symptoms, laboratory results on admission, treatment given. Treatment options will include (Steroids, plasma exchange, IVIG, antibiotics, mode of respiratory support). Primary outcomes will include; Death, duration of ICU stay, duration of mechanical ventilation, in-hospital complications. A regression model will be used to predict poor prognostic factors. Inclusion criteria: patients with confirmed PCR results for COVID-19 AND require ICU admission. Exclusion criteria: those with negative results, pediatric patients and those not requiring ICU admission.

Conditions

Interventions

TypeNameDescription
OTHERno intervention will be administered, this is a retrospective observational study.no intervention will be administered, this is a retrospective observational study.

Timeline

Start date
2021-01-01
Primary completion
2021-06-01
Completion
2021-07-01
First posted
2021-03-25
Last updated
2021-03-25

Locations

1 site across 1 country: Kuwait

Source: ClinicalTrials.gov record NCT04816786. Inclusion in this directory is not an endorsement.